EVARREST® is a flexible sealant patch embedded with human biologics and provides a durable mechanical structure for integrated clot formation. EVARREST® innovation offers superior hemostatic efficacy on the 1st-attempt.*
Seeing is Believing
Innovative solution that can stop problematic bleeding on the 1st attempt.* Surgeons need an innovative adjunctive-solution that can achieve 1st-attempt efficacy to minimize the disruptions and potential consequences of problematic bleeding situations.
EVARREST Innovation offers superior hemostatic efficacy on the 1st attempt. EVARREST® Fibrin Sealant Patch demonstrated superior hemostatic efficacy in 4 randomized controlled clinical trials across a spectrum of challenging bleeding situations and surgical procedures.
Ready to use, right out of the box. EVARREST® does not require preparation, mixing, moistening with saline or refrigeration, and has a shelf life of 30 months.1
EVARREST® Fibrin Sealant Patch demonstrated
superior hemostatic efficacy on the 1st attempt
in aortic reconstruction surgery
The PP results are similar to the intention-to-treat results from the randomized controlled clinical trials. The PP results represent patients
treated with no major violations to the clinical study protocol.
• EVARREST delivered positive results under the most challenging circumstances, such as application
to a vascular prosthetic graft for hypothermic patients undergoing cardiopulmonary bypass surgery 1
• Studies demonstrated no increased risk of thromboembolic events in patients treated with EVARREST2,3
EVARREST was studied in the following cardiovascular procedures1
Aortic aneurysm repair